Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO
来源：Reuters发布于 2026-10-08
Iambic Therapeutics, which is backed by Nvidia , is aiming to raise as much as $159.4 million in its US IPO, a regulatory filing showed on Thursday, as biotech companies remain a bright spot in an o...
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。